FindTrial
Sign In

Bupivacaine liposome infiltration for postoperative analgesia after caesarean section

Bupivacaine liposome infiltration for postoperative analgesia after caesarean section

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076315
Enrollment
Unknown
Registered
2023-10-01
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetrics

Interventions

experimental group: 133mg/20mL bupivacaine loposome for analgesia
control group:75mg/20mL bupivacaine for analgesia

Sponsors

Women and Children’s Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Age 20-35 years old, height 155-175 cm, gestational age 37-41 weeks, and weight 55-85 kg

Exclusion criteria

Exclusion criteria: allergic to bupivacaine

Design outcomes

Primary

MeasureTime frame
duration of analgesia;pain scores;hemodynamics;—

Secondary

MeasureTime frame
complications;—

Countries

China

Contacts

Public ContactZhang Wangping

Women and Children’s Hospital of Jiaxing

zhang650679@163.com+86 5758396131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026